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CEREBRAL TUBERCULOMAS IN AIDS PATIENTS
A forgotten diagnosis?
José E. Vidal1, Adrián V. Hernández2, Augusto C. Penalva de Oliveira3,4,
Alexandre Leite de Souza1, Geraldine Madalosso1, Paula R. Marques da Silva1, R. Dauar4
ABSTRACT - The human immunodeficiency virus (HIV) infection epidemics increased the prevalence, mul-
ti-drug resistance and disseminated forms of tuberculosis. The central nervous system (CNS) tuberculosis
has high mortality and morbidity, and it is usually divided into diffuse (meningitis) and localized (tubercu-
loma and abscess) forms. We report three cases of cerebral tuberculomas in AIDS patients: one with defin-
itive diagnosis, confirmed with histopathology, and two with probable diagnosis, based on clinical infor-
mation, radiological images, Mycobaterium tuberculosis isolation out of the CNS and adequate response
to antituberculous treatment. Further, we discuss diagnostic, therapeutic and prognostic issues of tuber-
culomas, with emphasis in the distinction from cerebral tuberculous abscesses. Despite of their infrequent
presentation, tuberculomas should be considered in the differential diagnosis of cerebral expansive lesions
in patients with AIDS.
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Tuberculomas cerebrais em pacientes com aids: um diagnóstico esquecido?
RESUMO - A epidemia da infecção pelo vírus da imunodeficiência humana (HIV) aumentou a prevalência,
multiresistência e formas disseminadas da tuberculose. O acometimento neurológico da tuberculose apre-
senta elevada morbidade e mortalidade, classificando-se em formas difusas (meningite) e localizadas
(tuberculoma e abscesso). Relatamos três casos de tuberculomas cerebrais em pacientes com AIDS: um deles
com diagnóstico definitivo, confirmado com histopatologia e dois com diagnóstico provável, baseado em
informação clínica, radiológica, isolamento de Mycobaterium tuberculosis fora do sistema nervoso central
e adequada resposta ao tratamento tuberculostático. Discutimos também aspectos diagnósticos, terapêu-
ticos e prognósticos dos tuberculomas, enfatizando suas diferenças com os abscesos tuberculosos cerebrais.
Apesar de serem relatados de forma infreqüente, os tuberculomas devem sempre ser considerados no diag-
nóstico diferencial das lesões expansivas cerebrais em pacientes com AIDS.
PALAVRAS-CHAVE: tuberculoma, tuberculose, sistema nervoso central, sindrome da imunodeficiência
adquirida.
Tuberculosis (TB) has become more frequent
since the emergence of human immunodeficien-
cy virus (HIV) infection epidemics. Nowadays, there
are important challenges, which complicate the ma-
nagement of HIV-TB co-infected patients. Among
them, it is emphasized the increase of disseminat-
ed and extra-pulmonary TB forms, the multi-drug
resistance and the increase in mortality1.
The central nervous system (CNS) TB is found in
5-10% of patients with pulmonary TB2. These cas-
es correspond to either latent infection reactivations
or disseminated infections. Tuberculous meningi-
tis is the most common clinical form and it is five
times more frequent in patients with HIV infection
than in patients without it3. The focal forms of CNS
tuberculosis are infrequently described and they are
divided into tuberculoma and abscess4.
We describe three cases of cerebral tuberculo-
ma in AIDS patients and discuss diagnostic, therape-
utic and prognostic issues, with emphasis in the dis-
tinction from cerebral tuberculous abscesses. This
study was ethically approved by the institutional
review boards of the Institute of Infectious Disease
Emilio Ribas, Sao Paulo, Brazil.
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CASES
Case 1 - A 36-year-old Brazilian man was admitted
in December 2002 with a seven-days history of tiredness,
headache, nausea and vomiting. He had diagnosed HIV
and cerebral toxoplasmosis in October 2002. The patient
irregularly used zidovudine, lamivudine, efavirenz, sulfa-
diazine, pyrimethamine, and folinic acid. On physical exa-
mination, he showed a decrease in consciousness level
and no focal neurological signs. Altered laboratory tests
included hemoglobin 9.2 g/dl, leucocytes 1100/mm3,
platelets 95000/mm3 and sodium 128 mmol/l. A chest X-
ray showed a scary lesion in upper right lung. Toxoplasma
gondii serology was positive and CD4+ lymphocytes
count was 7 cells/mm3. A cerebral computed tomogra-
phy (CT) scan showed a solitary lesion in the left cere-
bellum, with contrast enhancement and mass effect
(Fig 1). The cerebrospinal fluid examination (CSF) was
normal. Empirical treatment for toxoplasmic encephali-
tis with sulfadiazine 6 g, pyrimethamine 25 mg and fo-
linic acid 15 mg daily was initiated. Three weeks later,
a new CT scan showed increase in size of the cerebellar
lesion and surgery was indicated. The histological exam-
ination showed presence of few acid-fast bacilli (AFB),
necrotic tissue and absence of microabscesses. Investi-
gation for other causes, including bacteria and fungi,
were negative. Thus, treatment with isoniazid 400 mg,
rifampin 600 mg, pyrazinamide 2 g, and prednisone 50
mg daily was initiated. Four weeks later, the patient evi-
denced meaningful clinical and imaging improvement
and he was discharged to complete nine months of an-
tituberculous treatment.
Case 2 - A 31-year-old Brazilian woman was admit-
ted in August 2002 because of weight loss, tiredness, fe-
ver, headache and productive cough for four weeks and
a convulsive episode one week before. She had been
diagnosed as being infected with HIV infection since 1985
and she had Pneumocystis carinii pneumonia in 1999 and
pulmonary TB in 2001. The patient irregularly used zi-
dovudine, lamivudine, efavirenz and trimethoprim-sul-
famethoxazole. On physical examination, she had fever,
diffuse non-painful adenomegalia and no neurological
signs. Laboratory tests showed hemoglobin 8.6 g/dl,
leucocytes 2.900/mm3, alkaline phosphatase 460 UI/l,
aspartate aminotransferase 83 UI/l, alanine aminotransfe-
rase 62 UI/l and lactose dehydrogenase 657 UI/l. A chest
X-ray showed bilateral pleural thickness and enlarged
mediastinal area. Her tuberculin skin test, using purified
protein derivative (PPD), and T. gondii serology were neg-
ative. The CD4+ lymphocytes count was 31 cells/mm3
and the HIV viral load was 234000 copies/ml. An abdom-
inal ultrasonography evidenced hepatosplenomegalia,
intra-abdominal adenomegalia and ascitic fluid. A cere-
bral CT scan showed multiple nodular and ring-enhanc-
ing lesions (Fig 2A), and one lesion with central calcifica-
tion and ring-enhancement. The CSF was normal and a
cervical node biopsy yielded abundant AFB with caseous
necrosis. Isoniazid 400 mg, rifampin 600 mg, pyrazina-
mide 2 g, ethambutol 1.2 g, sulfadiazine 6 g, pyrime-
thamine 25 mg, and folinic acid 15 mg daily were initi-
ated. Three weeks later, the patient did not have any
clinical improvement and the cerebral lesions remained
unchanged. The culture of AFB yielded M. tuberculosis
resistant to rifampin. Streptomycin 1 g was added to iso-
niazid, pyrazinamide and ethambutol, and the toxoplas-
mosis treatment was stopped. One month later, the pa-
tient was asymptomatic and she was discharged to com-
Fig 1. Contrast-enhanced computed tomography scan of case
1, showing a large unique ring-enhancing lesion in the left cere-
bellum, sourrounded by discrete edema.
Fig 2. A. Contrast-enhanced computed tomography scan of case
2, showing multiple nodular and ring-enhancing lesions in
subcortical areas, with discrete edema. B. After two months of
treatment, CT scan showing absence of focal lesions.
plete nine months of treatment. Two months after, a CT
scan showed moderate cortical and subcortical atrophy
without focal lesions (Fig 2B).
Case 3 - A 30-year-old Brazilian woman was admit-
ted in August 2002 with a three-weeks history of fever,
productive cough, headache, abdominal pain, vomiting
and diarrhea. She had diagnosed HIV infection in June
2001 and she had a history of disseminated TB (pul-
monary and nodal) in September 2001, with abandon-
ment of antituberculous treatment at the third month.
On physical examination, the patient had important
weight loss, moderate dehydration, abdominal disten-
tion, hepatosplenomegalia, ataxia and psychomotor
slowness. Altered laboratory tests were hemoglobin
11.2 g/dl, leucocytes 3100/mm3, alkaline phosphatase 514
UI/l, aspartate aminotransferase 57 UI/l and alanine ami-
notransferase 53 UI/l, and lactose dehydrogenase 711 UI/l.
A chest X-ray showed multiple micronodular lesions in
both lungs compatible with miliary tuberculosis. The
PPD and T. gondii serology were negative, the CD4+
lymphocytes count was 35 cells/mm3 and the HIV viral
load was 54800 copies/ml. The direct examination of spu-
tum for AFB was positive. A CT scan showed two cere-
bellar lesions, one of them multiloculated (Fig 3A). The
CSF examination revealed a protein of 150 mg/L with
both normal glucose level and white cell count. No AFB
were seen on Ziehl-Neelsen staining and culture was neg-
ative. Treatment with isoniazid 400 mg, rifampin 600 mg,
pyrazinamide 2 g, and ethambutol 1.2 g daily was start-
ed. One month later, the patient evidenced important
clinical and imaging improvement and she was dischar-
ged to complete nine months of treatment. The culture
of sputum yielded M. tuberculosis sensible to isoniazid,
rifampin and pyrazinamide. Three months later, the pa-
tient was asymptomatic and had a normal cerebral CT
scan (Fig 3B).
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DISCUSSION
The introduction of highly active antiretroviral
therapy (HAART) improved significantly the survival
and quality of life of AIDS patients in developed
countries and in Brazil5. TB prevalence has also
decreased as a consequence of HAART. However,
TB is still a public health problem in Brazil and repre-
sents the most frequent AIDS-defining disease5.
There is limited information about focal forms
of cerebral TB in AIDS patients and recent reviews
over CNS opportunistic infections did not include
TB6,7. This is possible due to the fact that the num-
ber of CNS TB cases in developed countries is very
limited, as demonstrated in a detailed neuropatho-
logical study8. In the AIDS era, Lesprit et al.9 found
only 21 cases of cerebral TB (including tuberculo-
mas and abscesses), and Vidal et al.10 found nine
cases of tuberculous abscess. The lack of reports
of CNS TB in developing countries, where the TB
prevalence is high, can be due to underdiagnosis
and underregister of cases and, indeed, to the lack
of publications. 
Tuberculomas can develop through four patho-
physiological mechanisms. First, invasion of bacil-
li from the CSF (TB meningitis). Second, as a conse-
quence of a disseminated TB. Third, paradoxical
reaction in patients with antituberculous treat-
ment, with or without antiretrovirals. Finally, local
reactivation of latent foci2,11. Cerebral TB infec-
tion may produce local areas of cerebritis with
formation of tuberculomas. It is unknown why an
abscess is produced in some cases and in another
it is a tuberculoma. Farrar12 considers that if the
quantity of bacilli is high enough or the immuni-
ty is depressed, a focal cerebritis may progress to
an abscess. On the other hand, the most of authors
consider that the abscesses result from the liquefac-
tion of tuberculomas13. 
The focal forms of CNS TB show different anato-
mopathological characteristics, which were defined
by Whitener14. Tuberculomas have a central region
with caseous necrosis, a capsule of collagen and
giant multinuclear, epitheliod and mononuclear
cells. On the other hand, abscess require to fulfill
the following criteria: (1) macroscopic evidence
of pus, (2) inflammatory reaction in the abscess wall,
which consists of granulate vascular tissue and a-
cute and chronic inflammatory cells, and (3) de-
monstration of AFB in the purulent material or in
the abscess wall, or positive culture of M. tubercu-
losis. Definitive diagnosis of cerebral tuberculoma
needs histopathologic evidence in the cerebral tis-
Fig 3. A. Contrast-enhanced computed tomography scan of case
3, showing two cerebellar lesions, including one multiloculat-
ed mass lesion in the left cerebellum. B. After three months of
treatment, CT scan showing absence of focal lesions.
sue obtained by biopsy, trepanation or necropsy.
Probable diagnosis of tuberculomas requires epi-
demiological, clinical and laboratorial informa-
tion and also an adequate response to antitubercu-
lous treatment2.
The clinical presentation of tuberculomas and
tuberculous abscesses is similar to the main CNS ex-
pansive lesions in AIDS patients9,10. However, the
tuberculous abscesses usually have a more accelera-
ted clinical course. Therefore, it is important to per-
form a detailed anamnesis and physical examina-
tion to find exposure information, previous TB di-
sease and treatment as well as symptoms and signs
out of the CNS. 
Tomographic findings of the focal forms of CNS
TB are unspecific and less clear than the findings of
the magnetic resonance (MRI)4. However, it seems
that there is an adequate correlation between his-
topathological and tomographic findings of tuber-
culomas. The radiological presentation depends
on whether the granuloma is noncaseating, caseat-
ing with a solid center, or caseating with a liquid
center4. The noncaseating granulomas are round-
ed or oval, multiple, isodense or lightly hypodense
lesions, with nodular contrast enhancement. These
are the classical lesions described for tuberculo-
mas and they were present in the patient 2. The
caseating granulomas with solid center and caseat-
ing granulomas with liquid center are isodense or
hypodense lesions with annular contrast enhance-
ment. The degree of surrounding edema is variable
and is thought to be inversely proportional to the
maturity of the lesion4. Usually, the caseating gran-
ulomas with solid center show thicker walls. On the
other hand, the caseating granulomas with liquid
center may be undistinguishable from the bacter-
ial or TB abscesses. This fact was evident in patients
1 and 3. However, the TB abscesses might differ from
tuberculomas because they show a more rapid
course, usually have larger size (often > 3cm), thin-
ner walls, and mostly unique and multiloculated
lesions2,4,15. Moreover, there are tuberculomas which
are solitary and large (patient 1), multiloculated
(patient 3) and with an important mass effect9.
The “target sign”, defined as a central nest of calci-
fication or a central contrast enhancement sur-
rounded by a ring of enhancement, is characteris-
tic of tuberculomas16,17. However, recent studies
have suggested that only the “target sign” with cen-
tral calcification is pathognomonic of tuberculoma4.
Unfortunately, the “target sign” is an infrequent
finding4,15. 
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In contrast to the cerebral TB abscesses, which
require surgical and pharmacological treatment10,12,14,
tuberculomas generally respond quite well with
only pharmacological treatment16,17. Nevertheless,
like was verified in some of our patients, the differen-
tiation between this two diagnoses is difficult and
complicates the surgical decision.
We conclude that tuberculomas should be consi-
dered in the differential diagnosis of CNS expansi-
ve lesions in patients with AIDS. A careful individ-
ual evaluation, including clinical (anamnesis, phys-
ical examination), laboratorial (negative T. gondii
serology, evidence of TB out of the CNS) and imag-
ing information (previous or active images in chest
X-ray, “target sign” in cerebral CT) could increase
the diagnostic probability of tuberculoma. In con-
trast to TB abscesses, the conservative treatment of
tuberculomas usually determines a good outcome. 
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